Drawing for KARO BIO

USPTO serial 76311858

KARO BIO

Reviewed by CopyMark Law Group

Reg. 3390490Status 710
Filing date
Status date
Registration date
Mar 4, 2008
Examiner
FRENCH, CURTIS W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KARO BIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Francis J. Duffin

FRANCIS J DUFFIN WIGGIN & DANA LLP1 CENTURY TWRNEW HAVEN, CT 06510-7013UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary productsSECTION 8 - CANCELLED—
005Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; diagnostic kits for medical and veterinary purposes, namely, assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compoundsSECTION 8 - CANCELLED—
010Diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity or biologically active substances, such as receptors and enzymes, and to identify antibacterial compoundsSECTION 8 - CANCELLED—
042Pharmaceutical research services; pharmaceutical advisory services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; provision of medical information; veterinary laboratory servicesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2014C8..CANCELLED SEC. 8 (6-YR)—
Mar 4, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 30, 2008DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jan 30, 2008CORVREVIEW OF CORRESPONDENCE COMPLETE—
Oct 29, 2007MAILPAPER RECEIVED—
Jun 15, 2006IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 5, 2006D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jan 9, 2006EX3GSOU EXTENSION 3 GRANTED—
Dec 7, 2005EXT3SOU EXTENSION 3 FILED—
Dec 7, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 20, 2005EX2GSOU EXTENSION 2 GRANTED—
Jun 13, 2005EXT2SOU EXTENSION 2 FILED—
Jun 13, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2004EX1GSOU EXTENSION 1 GRANTED—
Dec 14, 2004EXT1SOU EXTENSION 1 FILED—
Dec 14, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 20, 2004CFITCASE FILE IN TICRS—
Jun 15, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 23, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2004NPUBNOTICE OF PUBLICATION—
Jan 9, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 23, 2003EMRVEMAIL RECEIVED—
Dec 22, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 3, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2003UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Apr 10, 200344DDSEC. 44(D) CLAIM DELETED—
Apr 10, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2003MAILPAPER RECEIVED—
Feb 25, 2003CNSLLETTER OF SUSPENSION MAILED—
Feb 24, 2003DOCKASSIGNED TO EXAMINER—
Dec 23, 2002MAILPAPER RECEIVED—
Jun 4, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 28, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance